BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rani B, Cao Y, Malfettone A, Tomuleasa C, Fabregat I, Giannelli G. Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. World J Gastroenterol 2014; 20(15): 4128-4140 [PMID: 24764651 DOI: 10.3748/wjg.v20.i15.4128]
URL: https://www.wjgnet.com/1948-5182/full/v20/i15/4128.htm
Number Citing Articles
1
Yi Jin, Dayue Tong, Junjie Shen, Jianyong Yang, Jiaping Li. Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar ratsTumor Biology 2014; 35(9): 9079 doi: 10.1007/s13277-014-2161-0
2
Zhen Lu, Yun-Hong Xia, Min Zhao, Bing Zhang, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Jin-Ling Bi, Guo-Lin Jiang. DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growthOncotarget 2017; 8(33): 54993 doi: 10.18632/oncotarget.18990
3
M. Bouattour, E. Raymond, S. Faivre. Carcinome hépatocellulaire : nouveaux concepts, nouvelles molécules et nouvelles approchesOncologie 2017; 19(5-6): 168 doi: 10.1007/s10269-017-2712-2
4
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal CancersTranslational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
5
Yun-Hong Xia, Zhen Lu, Min Zhao, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Guo-Lin Jiang. Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cellsOncotarget 2017; 8(33): 55084 doi: 10.18632/oncotarget.19027
6
Rui Peng, Guang-Xi Zhao, Jing Li, Yu Zhang, Xi-Zhong Shen, Ji-Yao Wang, Jian-Yong Sun. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 <i>in vivo</i>World Journal of Gastroenterology 2016; 22(12): 3341-3354 doi: 10.3748/wjg.v22.i12.3341
7
Meng-Hsien Chuang, Jinghua Tsai Chang, Li-Jin Hsu, Ming-Shiou Jan, Fung-Jou Lu. Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular CarcinomaIntegrative Cancer Therapies 2017; 16(4): 516 doi: 10.1177/1534735416664173
8
Heeva Baharlou, Nicolas P. Canete, Anthony L. Cunningham, Andrew N. Harman, Ellis Patrick. Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis StrategiesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02657
9
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1396-4
10
Alvin Man Lung Chan, Jin Min Cheah, Yogeswaran Lokanathan, Min Hwei Ng, Jia Xian Law. Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic ReviewInternational Journal of Molecular Sciences 2023; 24(4): 4026 doi: 10.3390/ijms24044026
11
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
12
Mona Abd El-Rahman Abu El-Makarem, Douaa Mohammed Sayed, Ragaa Abdelshaheed Matta, Mahmoud Ragab Mohamed, Manal Ameer Abd El-Malak, Nehal Ibrahim Abbas. Interaction of peripheral CD4+CD25+CD127− Tregs with prolactin in HCV hepatocellular carcinoma: oncogenic or immunogenic mechanismsEgyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00250-2
13
Mansooreh Ahmadian, Christian Rickert, Angela Minic, Julia Wrobel, Benjamin G. Bitler, Fuyong Xing, Michael Angelo, Elena W. Y. Hsieh, Debashis Ghosh, Kimberly R. Jordan, Virginie Uhlmann. A platform-independent framework for phenotyping of multiplex tissue imaging dataPLOS Computational Biology 2023; 19(9): e1011432 doi: 10.1371/journal.pcbi.1011432
14
Liren Qian, Delia Dima, Cristian Berce, Yu Liu, Ioana Rus, Lajos-Zsolt Raduly, Yi Liu, Bobe Petrushev, Ioana Berindan-Neagoe, Alexandru Irimie, Alina Tanase, Ancuta Jurj, Jianliang Shen, Ciprian Tomuleasa. Protein dysregulation in graft versus host diseaseOncotarget 2018; 9(1): 1483 doi: 10.18632/oncotarget.23276
15
Marcelo M. Rodríguez, Esteban Fiore, Juan Bayo, Catalina Atorrasagasti, Mariana García, Agostina Onorato, Luciana Domínguez, Mariana Malvicini, Guillermo Mazzolini. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12Molecular Therapy 2018; 26(12): 2738 doi: 10.1016/j.ymthe.2018.09.012
16
Hiroshi Yasuda, Masatoshi Nakagawa, Hirofumi Kiyokawa, Eisaku Yoshida, Toru Yoshimura, Naohiko Koshikawa, Fumio Itoh, Motoharu Seiki. Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A ReviewInternational Journal of Molecular Sciences 2019; 20(1): 226 doi: 10.3390/ijms20010226
17
Gianluigi Giannelli, Bhavna Rani, Francesco Dituri, Yuan Cao, Giuseppe Palasciano. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironmentGut 2014; 63(10): 1668 doi: 10.1136/gutjnl-2014-307323
18
Luciana R. Gomes, Alexandre T. Vessoni, Carlos F.M. Menck. Microenvironment and autophagy cross-talk: Implications in cancer therapyPharmacological Research 2016; 107: 300 doi: 10.1016/j.phrs.2016.03.031
19
Rosanna Scialpi, Valentina Arrè, Gianluigi Giannelli, Francesco Dituri. Laminin-332 γ2 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma CellsCancers 2023; 15(2): 373 doi: 10.3390/cancers15020373
20
Chun-yu Huang, Hua Wang, Wei Liao, Feng Han, Yong-qiang Li, Shu-wei Chen, Xiang-ming Lao. Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular CarcinomaJournal of Immunotherapy 2017; 40(5): 175 doi: 10.1097/CJI.0000000000000166
21
Huisheng Liu, JiaYuan Zhong, JiaQi Hu, ChongYin Han, Rui Li, XueQing Yao, ShiPing Liu, Pei Chen, Rui Liu, Fei Ling. Single-cell transcriptomics reveal DHX9 in mature B cell as a dynamic network biomarker before lymph node metastasis in CRCMolecular Therapy - Oncolytics 2021; 22: 495 doi: 10.1016/j.omto.2021.06.004
22
Lunjie Lu, Jun Zhou, Jingying Zhang, Jun Che, Yang Jiao, Yusong Zhang. Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice ModelEvidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/4097398
23
Dalma Deak, Cristina Pop, Alina-Andreea Zimta, Ancuta Jurj, Alexandra Ghiaur, Sergiu Pasca, Patric Teodorescu, Angela Dascalescu, Ion Antohe, Bogdan Ionescu, Catalin Constantinescu, Anca Onaciu, Raluca Munteanu, Ioana Berindan-Neagoe, Bobe Petrushev, Cristina Turcas, Sabina Iluta, Cristina Selicean, Mihnea Zdrenghea, Alina Tanase, Catalin Danaila, Anca Colita, Andrei Colita, Delia Dima, Daniel Coriu, Hermann Einsele, Ciprian Tomuleasa. Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic LeukemiaFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02856
24
Gianluigi Giannelli, Wolfgang Mikulits, Steven Dooley, Isabel Fabregat, Aristidis Moustakas, Peter ten Dijke, Piero Portincasa, Peter Winter, Richard Janssen, Stefano Leporatti, Blanca Herrera, Aranzazu Sanchez. The rationale for targeting TGF‐β in chronic liver diseasesEuropean Journal of Clinical Investigation 2016; 46(4): 349 doi: 10.1111/eci.12596
25
Francesco Dituri, Rosanna Scialpi, Tannin A. Schmidt, Martina Frusciante, Serena Mancarella, Luigi Giovanni Lupo, Erica Villa, Gianluigi Giannelli. Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitroCell Death & Disease 2020; 11(11) doi: 10.1038/s41419-020-03180-8
26
Yuri Miyazoe, Satoshi Miuma, Hisamitsu Miyaaki, Yasuko Kanda, Suguru Nakashiki, Ryu Sasaki, Masafumi Haraguchi, Hidetaka Shibata, Takuya Honda, Naota Taura, Kazuhiko Nakao. Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP‑1 cells Biomedical Reports 2020;  doi: 10.3892/br.2020.1279
27
Florian Cabillic, Anne Corlu. Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular CarcinomaGastroenterology 2016; 151(4): 607 doi: 10.1053/j.gastro.2016.06.052
28
Jamie L. Hernandez, Jaehyung Park, Shan Yao, Anna K. Blakney, Hienschi V. Nguyen, Bob H. Katz, Jeffrey T. Jensen, Kim A. Woodrow. Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implantsBiomaterials 2021; 273: 120806 doi: 10.1016/j.biomaterials.2021.120806
29
Helena Degroote, Sander Lefere, Astrid Vandierendonck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher. Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma modelsOncotarget 2021; 12(6): 562 doi: 10.18632/oncotarget.27906
30
Roman A. Anisimov, Dmitry A. Gorin, Anatolii A. Abalymov. 3D Cell Spheroids as a Tool for Evaluating the Effectiveness of Carbon Nanotubes as a Drug Delivery and Photothermal Therapy AgentsC 2022; 8(4): 56 doi: 10.3390/c8040056
31
Francesco Dituri, Gianluigi Gigante, Rosanna Scialpi, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli. Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular CarcinomaCancers 2022; 14(8): 1902 doi: 10.3390/cancers14081902